Article ID Journal Published Year Pages File Type
3284273 Clinical Gastroenterology and Hepatology 2009 6 Pages PDF
Abstract
When international treatment guidelines are strictly followed, Crohn's disease patients can achieve high rates of remission and low rates of morbidity at 5 years. Indiscriminate use of biologic agents therefore is not appropriate for all patients with moderate-to-severe disease.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , ,